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The current study aimed at identifying the role of seizure types and 
related clinical features in differentiation between neurometabolic 
disorders and other causes of seizure.
Materials & Methods
The current cross sectional study was conducted at two referral 
children hospitals in Tehran, Iran, from 2011 to 2018. The study 
population included 120 patients presenting with seizure due to 
neurometabolic disorders and 120 cases due to other causes. The types 
of seizure and related clinical findings were assessed in both groups.
Results
There was a significant difference in the frequency of seizure types in 
the two groups. Tonic and myoclonic seizures as well as infantile spasm 
were observed more commonly in the patients with neurometabolic 
disorders, while atonic, partial and generalized tonic-clonic seizures 
were more common in the control group. In addition, frequency of 
refractory seizure, age at onset of seizure, and pattern of involvement 
in brain imaging were helpful for seizure differentiation.
Conclusion
The pattern of seizure and related findings varied in patients with 
metabolic disorders, and was helpful for seizure differentiation. Thus, 
these factors can contribute to early diagnosis and treatment.
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Introduction
Inborn Error of metabolism (IEM) is a group of 
disorders in which genetic abnormalities at the 
cellular level result in the lack or dysfunction 
of specific enzymes, cofactors, or transporters 
required for fatty acid, amino acid, or carbohydrate 
metabolism (1). Some IEM disorders affecting the 
nervous system are considered as neurometabolic 
disorders. Brain is susceptible to damage in such 
situations (2). Seizure is a common manifestation 
in neurometabolic disorders and may be considered 
as a presenting symptom. Epilepsy is not rare in the 
general population (seizures occur in one per 1000 
live births) (3). Seizure is a common symptom of 
metabolic diseases reported in about 200 different 
IEM disorders (3); however, there are limited data 
on the certain seizure patterns in patients with 
metabolic disorders (1, 2, 4-6). Therefore, some 
specific features are reported in seizures along 
with neurometabolic disorders (7).
Early onset seizures and refractory seizures 
accompanied by developmental disabilities are 
commonly observed in IEM disorders (8).
Regarding seizure, clinical findings are often 
nonspecific (9, 10), and high index of suspicion is 
needed to consider neurometabolic disturbances. 
Sometimes, specific features of seizure and other 
clinical-related findings may indicate metabolic 
disorders. Early detection of disturbance and 
appropriate management of pathological conditions 
can prevent comorbidity and improve the quality 
of life. Therefore, the current case-control study 
aimed at assessing the seizure pattern and its related 
findings in patients with neurometabolic disorders 
in order to report common types of seizure and 
other clinical manifestations to differentiate 
between neurometabolic disorders and other 
causes of seizure.
Materials & Methods
 The current case-control study aimed at comparing 
the characteristics of seizure and other valuable 
clinical findings in patients with neurometabolic 
disorders and those of a control group. The study 
was performed in the pediatric neurology wards of 
Mofid Children’s and Imam Hossein hospitals, two 
tertiary care referral centers, from 2011 to 2018, in 
Tehran, Iran. A total of 213 patients diagnosed with 
neurometabolic disorders were enrolled. Diagnosis 
was made according to clinical manifestations, 
physical and neurologic examinations, neuro-
imaging findings, and finally with enzymatic-, 
biochemistry-, or genetic-based studies. Videlicet, 
the diagnosis of metabolic disorders, was based 
on biochemical tests (i e, serum acylcarnitine 
profile, and organic acidurias in organic acidemia, 
serum amino acids in aminoacidopathy by high-
performance liquid chromatography, very long-
chain fatty acid in peroxisomal disorders, and 
enzyme assay in storage diseases). In some 
challenging cases, the right diagnosis was 
confirmed using genetic tests.  
Of the 213 studied subjects, 55% (n=120) had 
seizure disorders. These patients were considered 
as the case group. Neurometabolic disorders 
in the case group included organic academia, 
aminoacidopathy, and urea cycle disorders, storage 
disease, leukodystrophy, fatty acid oxidation 
disorders, and peroxisomal diseases. The age range 
of the patients was 1 to 196 months.
The control group included 120 children within the 
age range of 1 to 196 months referred to the same 
hospitals with seizure for other reasons (i e, genetic 
disorders, acquired disorders such as brain tumors, 
inflammatory diseases, electrolyte imbalances, 
trauma, withdrawal syndromes, hemorrhage, 
hypoxic ischemic encephalopathy, prematurity 
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insult, brain structural disorders, and specific 
epileptic syndromes).
The exclusion criteria were neonatal period, febrile 
convulsion, and incomplete data. The clinical 
findings including demographic information, 
age at onset of seizure, family history of seizure, 
developmental delay or regression, consanguinity, 
type of seizure (tonic or myoclonic seizure, infantile 
spasm, and atonic, partial, generalized tonic-clonic 
(GTC) or absence seizure), refractory seizure, and 
specific pattern of electroencephalography (EEG), 
as well as magnetic resonance imaging (MRI) 
results were recorded in a form. Other findings 
such as eye abnormalities, skin and hair problems, 
and hearing impairments were also recorded.
Finally, the characteristics were compared between 
the two groups. The study was approved by the 
Ethics Committee of Shahid Beheshti University 
of Medical Sciences, Tehran, Iran. All patients 
were included in the current study with parental 
informed consent.
Statistical analysis
Continuous data were expressed as mean ± standard 
deviation and categorical data as frequency and 
percentage. In order to compare the characteristics 
and outcomes between the two groups, independent 
samples t-test, the Mann Whitney and Chi-squared 
tests were applied and the exact P-values were 
calculated whenever needed. The significance 
level was set at 0.05 and SPSS version 21 was used 
for data analysis. 
Results
Of the visited 213 patients with neurometabolic 
disorders, 55% (n=120) had seizure disorder (case 
group). Pattern of seizure and related clinical 
findings in the case group were compared with 
those of the 120 cases with seizure secondary to 
other causes.
Mean age of the patients at the time of evaluation 
was significantly different between the case and 
control groups (39.86± 47.43 vs. 73.76± 51.18 
months; P=0.001). There were 56 female and 64 
male patients in the case group and 60 female and 
60 male patients in the control group, indicating 
an insignificant difference between the groups in 
this regard (P=0.698). Age at the onset of seizures 
was significantly lower in the case group than the 
control group (13.20 ± 21.40 vs. 40.90 ± 36.50 
months; P <0.001), data are shown in Table 1.
Distribution of the types of seizure was significantly 
different between the two groups (P <0.001); tonic 
and myoclonic, infantile spasm, and mixed-type 
seizures were more common in the case group, 
while atonic, absence, partial, and GTC seizures 
were more frequently observed in the control 
group, data are shown in Table 3. Overall, 80.6% 
of tonic seizures were observed in the case group, 
while just fewer than 20% of them occurred in the 
control group. Two-thirds of myoclonic seizures 
happened in patients with metabolic disorders, and 
a third in the control group. Furthermore, 57.1% 
of infantile spasm cases were observed in the case 
group, and 62.5% of mixed-type seizures were 
reported in the case group. In contrast, almost 89% 
of partial seizures were detected in the control 
group, while only 11% of them happened in the 
case group. 
Similarly, around 93% of atonic seizures were 
detected in the control group, and all patients 
with absence seizure were in the control group. In 
addition, 79.7% of GTC seizures were observed 
in the control group, and refractory seizure was 
observed in 14.5% of the case and 4.2% of the 
control groups. There was no significant difference 
between the case and control groups in terms of the 
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family history of seizure (34 (28.3%) in cases vs. 
31 (25.8%) in controls; P=0.663).
Parental consanguinity was significantly higher in 
the case group subjects compared with the control 
group ones (82.5% vs. 22.5%; P <0.001), Table 
3. Overall, 95% of patients in the case group and 
5% in the control group had abnormal neurologic 
status (P <0.001). For example, ocular problems 
were observed in 31.7% of the cases and none of 
the controls (P <0.001). Dysmorphic feature was 
noted in 10.8% of the subjects in the case group 
and none of the control group patients (P <0.001). 
Skin and hair problems were observed in a quarter 
of the patients in the case group and none of the 
control group subjects (P <0.001). Also, hearing 
impairment was detected in 9.1% of the case 
group patients (5.8% with hyperacusis and 3.3% 
with hearing loss) and none of the control group 
subjects (P=0.009).
Growth velocity of head circumference was 
considerably different between the case and control 
groups (60% vs. 5.8%; P <0.001). Accordingly, 
microcephaly appeared in 27.5% of case group 
subjects and 4.2% of the control patients, in the 
same vein, macrocephaly was observed in 23.3% 
of cases and 1.7% of the controls. 
In patients with neurometabolic disorders, 92.5% 
had abnormal developmental status, whilst only 
22.5% of the patients in the control group had 
developmental disability. In addition, of these 
patients, in the case group 56.7% appeared with 
developmental delay, 20.8% with delay plus 
regression, and 15% with regression, while in 
the control group only developmental delay was 
observed without regression. Developmental 
regression was observed in 35.8% of the case 
group subjects, which was not detected in any of 
the patients in the control group (P=0.0002). 
Brain MRI Valuable findings were observed in 
62.5% of the case vs 21.7% of the ones in the 
control groups, which were significantly different 
(P=0.0001). In patients with metabolic disorders, 
white matter involvement was seen in 23 and brain 
atrophy in 50 cases. In six patients brain atrophy 
was associated  with basal ganglia involvement  , 
and   two  cases  had white matter involvement 
along with  basal ganglia anomaly. Infarct was 
observed in two patients ,too.(Figure 1).
Table 1: Demographic Characteristics of the Study Groups
Group
Variable





Mean ± SD Mean ± SD P-value
Age (mn) 39.86 ± 47.43 73.76 ± 51.18 <0.001
Age at onset of seizures (mn) 13.20 ± 21.40 40.90 ± 36.50 <0.001
N (%) N (%)
Gender                                        
Male 56 (46.67) 60 (50)
0.698Female 64 (53.33) 60 (50)
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Table 2: The Frequency of Seizure Types in the Case and Control Groups
Group
Control Case Total
Seizure Type (N=120) (N=120) (N=240)
Tonic 6 (5) 35 (29.2) 41 (17.1)
Myoclonic 3 (2.5) 10 (8.3) 13 (5.4)
Atonic 13 (10.8) 2 (1.7) 15 (6.3)
Partial 24 (20) 5 (4.2) 29 (12.1)
Generalized tonic-
clonic
55 (45.8) 27 (22.5) 82 (34.2)
Absence 7 (5.8) 1 (0.8) 8 (3.3)
IS 3 (2.5) 8 (6.7) 11 (4.6)
Others 3 (2.5) 19 (15.8) 22 (9.2)
Mixed 6 (5) 13 (10.8) 19 (7.9)
Data are expressed as frequency (percent).
IS: Infantile spasm
Table 3: Comparison of Related Clinical Findings in the Case and Control Groups
Group
Variable





Mean ± SD Mean ± SD P-value
N (%) N (%)
Refractory seizure 18 (14.5) 5 (4.2) <0.001
Abnormal head circumference 72 (60) 7 (5.8) <0.001
Ocular problems 38 (31.7) 0 (0) <0.001
Skin/hair problems 30 (25) 0 (0) <0.001
Hearing impairment 11 (9.1) 0 (0) <0.001
Hyperacusis 7 (5.8)
Hearing loss 4 (3.3)
Developmental delay 111 (92.5) 27 (22.5) <0.001
Developmental regression 43 (35.8) 0 (0) <0.001
Parental consanguinity 99 (82.5) 27 (22.5) <0.001
Positive family history 34 (28.3) 31 (30.8) 0.771
Abnormal EEG 98 (81.6) 85 (70.8) 0.069
Abnormal brain MRI 75 (62.5) 26 (21.7) <0.001
EEG: electroencephalography; MRI: magnetic resonance imaging
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Discussion 
Despite the rarity of the IEM disorders, they are 
important and fairly common causes of seizure in 
children. When patients present with seizure, it is 
challenging to diagnose neurometabolic disorders 
(1). In patients with metabolic diseases, severe 
morbidity and mortality can be prevented by 
early detection and proper management strategies. 
However, diagnosis in such patients can be 
problematic and expensive, thus, diagnostic keys 
are important in this process. The current study 
evaluated 213 patients with metabolic disorders, 
55% (n=120) of whom had seizure disorders. 
Patients with seizure due to neurometabolic 
disorders were assessed and compared with 120 
patients with seizure, secondary to other causes, 
and then the key points were specified to metabolic 
disorders. A clear difference was observed in the 
type of seizures between the two groups; tonic and 
myoclonic seizures, infantile spasm, and mixed 
seizures were considerably more common in 
patients with neurometabolic disorders, whereas 
partial, atonic, absence, and GTC seizures were 
observed more frequently in the control group.
Previous studies revealed that seizure is a common 
presentation of neurometabolic disorders to such 
an extent that 40%-90% of patients with such 
problems experience seizure (2, 11). Several 
studies indicated that some types of seizure are 
more common in neurometabolic disorders; e g, 
infantile spasm and myoclonic seizure (2, 12). 
In the current study, seizure started earlier in 
patients with neurometabolic disorders than the 
subjects in the control group (mean age: 39.86 
vs. 73.76 months), which was in accordance with 
previous studies that reported ≤12 months old 
Figure 1: Abnormal MRI Distribution in the Case Group
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similar to the age at onset of seizure in 50%-60% 
of patients with neurometabolic disorders (1, 12). 
Age is an important factor to determine the type 
of metabolic disorder. In some of these disorders, 
seizure presents in lower ages, and in some 
others in higher ages; for example, in non-ketotic 
hyperglycinemia or pyridoxine deficiency, seizures 
start from the neonatal period (3); besides, the type 
of seizure also depends on age. Due to incomplete 
synchronization in infancy, GTC is rarely observed, 
and absence seizures are usually not observed until 
the age of two years. On the other hand, infantile 
spasm is observed during the neonatal period (13); 
thus, probably due to the occurrence of metabolic 
diseases at earlier ages, certain types of seizure are 
more common in such patients.
At baseline, 14.5% of patients with metabolic 
disorders showed refractory seizure symptoms 
versus 4.2% in the control group. It was clear that 
some of these patients needed special treatments 
for correction of metabolic abnormalities, and 
their seizure could not be controlled solely with 
antiepileptic drugs (14).
Overall, 95% of the patients with neurometabolic 
disorders had abnormal physical manifestations, 
while the rate was only 5% in the control group. 
These abnormalities included vision and ocular 
problems in one-third of the patients in the case 
group, dysmorphic face in 10.8%, and hair and 
skin problems in 25% of the subjects in the same 
group of patients, whilst none of these problems 
were observed in the control group. In addition, 
abnormal head circumference was observed in 
60% of the patients in the case group versus 
5.8% of the controls, hearing impairment was 
observed in 9.1% of the patients in the case group, 
but none in the controls. Also, developmental 
disability was observed in 92.5% of the case group 
subjects, which was 22% in those of the control 
group, additionally, 35.8% of the patients with 
neurometabolic disorders revealed developmental 
regression, which was not observed in the control 
group. The current study findings were in line 
with the results of previous studies; they reported 
multi-systemic presentations in patients with 
neurometabolic disorders including macrocephaly, 
microcephaly, dysmorphic features, skin lesion, 
foul odor, eye abnormalities, hearing impairment, 
and neuropathy (14, 15).
The presence of some of these findings helped to 
diagnose some specific metabolic disorders; for 
example, cherry-red spot was common in most 
patients with GM2 gangliosidosis or skin lesion 
was a diagnostic key for biotinidase deficiency 
(16, 17). Developmental regression is an important 
diagnostic key for metabolic diseases when 
patients present with seizure, which is less expected 
concomitant with seizures due to other causes (10).
In the current study results, the percentage 
of parental consanguinity in patients with 
neurometabolic disorders was significantly higher 
than that of controls (82.5% vs. 22.5%), which was 
in accordance with the findings of Sarar and Masry 
that reported the frequency of neurometabolic 
disorders in 75% and 77.1% of patients with 
parental consanguinity, respectively (1, 4); it can be 
explained by the fact that neurometabolic disorders 
are among autosomal recessive disorders.
 Family history of seizure disorders was positive 
in approximately one-third of the current study 
patients in both groups, and there was no 
significant difference between them in this respect. 
Previous studies revealed positive family history 
in 22%-33% of patients with neurometabolic 
disorders (1, 12), which was in accordance with 
the current study results, but those studies did not 
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have a control group for comparison. Nevertheless, 
according to the current study design, history of 
seizure (not seizure plus neurometabolic disorder) 
was considered in the patients; thus, no significant 
relationship was observed in this regard, although 
it might exist. 
In the current study, electroencephalographic 
features did not help for the diagnosis of IEM. In 
other assessments, the distinctive EEG pattern was 
not proved for any IEM disorders, either (4).
Brain MRI in 62.5% of the patients with 
neurometabolic disorders elicited valuable 
diagnostic findings, while only 21.7% of the 
patients in the control group had abnormal brain 
MRI. In most of such patients, imaging was a great 
help to determine the type of metabolic disease; 
for example, MRI in all patients with Canavan 
disease showed subcortical, periventricular white 
matter leukodystrophy (18) or leukodystrophic 
changes in the posterior region with marginal 
post-contrast enhancement that was specific to 
adrenoleukodystrophy (ALD) (19). Additionally, 
Shamima reported abnormal brain imaging in 
two-thirds of patients and noted that it can be the 
diagnostic key for some types of neurometabolic 
disorders (3). Moreover, Zimmerman in his 
study underscored MRI and MR spectroscopy as 
valuable methods to evaluate children suspected of 
neurometabolic disorders (17). 
Suvasini et al., noted that the points for diagnosis of 
neurometabolic disorders in patients with epilepsy 
contained: positive family history, consanguinity 
of marriage, developmental disability, some other 
neurological manifestation such as hypotonia, 
abnormal ophthalmological exam, movement 
disorders, and some related systemic findings such 
as organomegaly, failure to thrive, cardiomegaly, 
etc (20).
Ultimately, when managing a patient with epilepsy, 
neurometabolic disorders should be suspected if 
the patient meets one or more of the following 
criteria:
1. Certain types of seizures including tonic, 
myoclonic, infantile spasm, or mixed-type 
seizure
2. Seizures that initiated at a young age and 
resistant to common anti-epileptic drugs
3. Abnormal findings, in favor of metabolic 
disorders, such as macrocephaly or 
microcephaly, organomegaly, skin and hair 
problems, eye problems, hearing impairment, 
and developmental delay, especially regression 
4. The offspring of a consanguineous marriage
5.  Positive family history of the same disease
6.  Brain MRI indicating a diagnostic finding such 
as leukodystrophy or basal ganglia involvement
If patients with seizure do not meet the mentioned 
criteria, assessment for metabolic disorders such as 
the underlying disease cannot be helpful.
In Conclusion, In patients with seizure, some 
related findings sush as specific patterns of seizure, 
onset of seizure at a low age, refractory seizures, 
developmental disability, specially developmental 
regression, parental consanguinity, and key 
points in exams such as hearing or visual system 
abnormality, hair and skin abnormalities, and 
abnormal head circumference along with specific 
pattern of brain involvement in MRI are valuable 
keys to identify metabolic diseases.
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